In Silico Study, Synthesis and Antimalarial Evaluation of Hybrid Pyridine Substituted Pyrazole 1,3,5-triazine Derivatives

Overview

Journal 3 Biotech

Publisher Springer

Specialty Biotechnology

Date 2024 Nov 18

PMID 39554985

Authors

Biswajit Devanath

Bonita Chetia

Anshul Shakya

Surajit Kumar Ghosh

Saurav Jyoti Patgiri

Ipsita Pal Bhowmick

Udaya Pratap Singh

Hans Raj Bhat

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-04129-w.

References

Roux A, Maharaj L, Oyegoke O, Akoniyon O, Adeleke M, Maharaj R . Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Sub-Saharan Africa-A Review. Front Genet. 2021; 12:668574. PMC: 8267899. DOI: 10.3389/fgene.2021.668574. View

Ippolito M, Moser K, Kabuya J, Cunningham C, Juliano J . Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy. Curr Epidemiol Rep. 2021; 8(2):46-62. PMC: 7955901. DOI: 10.1007/s40471-021-00266-5. View

Adhikari N, Choudhury A, Shakya A, Ghosh S, Patgiri S, Singh U . Design and development of novel N-(4-aminobenzoyl)- l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitor: An in-silico and in-vitro study. J Biochem Mol Toxicol. 2022; 37(4):e23290. DOI: 10.1002/jbt.23290. View

Badshah S, Ullah A, Ahmad N, Almarhoon Z, Mabkhot Y . Increasing the Strength and Production of Artemisinin and Its Derivatives. Molecules. 2018; 23(1). PMC: 6017432. DOI: 10.3390/molecules23010100. View

Sato S . Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology. J Physiol Anthropol. 2021; 40(1):1. PMC: 7792015. DOI: 10.1186/s40101-020-00251-9. View

Shoichet B, Kuntz I . Protein docking and complementarity. J Mol Biol. 1991; 221(1):327-46. DOI: 10.1016/0022-2836(91)80222-g. View

Gogoi P, Shakya A, Ghosh S, Gogoi N, Gahtori P, Singh N . In silico study, synthesis, and evaluation of the antimalarial activity of hybrid dimethoxy pyrazole 1,3,5-triazine derivatives. J Biochem Mol Toxicol. 2020; 35(3):e22682. DOI: 10.1002/jbt.22682. View

Srivastava J, Pillai G, Bhat H, Verma A, Singh U . Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase. Sci Rep. 2017; 7(1):5851. PMC: 5517562. DOI: 10.1038/s41598-017-05934-5. View

Singh U, Pathak M, Dubey V, Bhat H, Gahtori P, Singh R . Design, synthesis, antibacterial activity, and molecular docking studies of novel hybrid 1,3-thiazine-1,3,5-triazine derivatives as potential bacterial translation inhibitor. Chem Biol Drug Des. 2012; 80(4):572-83. DOI: 10.1111/j.1747-0285.2012.01430.x. View

10.

Bekhit A, Hymete A, Damtew A, Mohamed A, Bekhit A . Synthesis and biological screening of some pyridine derivatives as anti-malarial agents. J Enzyme Inhib Med Chem. 2011; 27(1):69-77. DOI: 10.3109/14756366.2011.575071. View

11.

Veber D, Johnson S, Cheng H, Smith B, Ward K, Kopple K . Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002; 45(12):2615-23. DOI: 10.1021/jm020017n. View

12.

Singh U, Bhat H, Gahtori P . Antifungal activity, SAR and physicochemical correlation of some thiazole-1,3,5-triazine derivatives. J Mycol Med. 2013; 22(2):134-41. DOI: 10.1016/j.mycmed.2011.12.073. View

13.

Plowe C . Malaria chemoprevention and drug resistance: a review of the literature and policy implications. Malar J. 2022; 21(1):104. PMC: 8943514. DOI: 10.1186/s12936-022-04115-8. View

14.

Sahu S, Ghosh S, Gahtori P, Singh U, Bhattacharyya D, Bhat H . In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor. Pharmacol Rep. 2019; 71(5):762-767. DOI: 10.1016/j.pharep.2019.04.006. View

15.

Rieckmann K, Campbell G, Sax L, Mrema J . Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet. 1978; 1(8054):22-3. DOI: 10.1016/s0140-6736(78)90365-3. View

16.

Saha A, Choudhury A, Adhikari N, Ghosh S, Shakya A, Patgiri S . Molecular docking and antimalarial evaluation of hybrid -aminobenzoic acid 1,3,5 triazine derivatives inhibition of -DHFR. J Biomol Struct Dyn. 2023; 41(24):15520-15534. DOI: 10.1080/07391102.2023.2208207. View

17.

Manohar S, Khan S, Rawat D . 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum. Chem Biol Drug Des. 2013; 81(5):625-30. DOI: 10.1111/cbdd.12108. View

18.

Al-Awadhi M, Ahmad S, Iqbal J . Current Status and the Epidemiology of Malaria in the Middle East Region and Beyond. Microorganisms. 2021; 9(2). PMC: 7915327. DOI: 10.3390/microorganisms9020338. View

19.

Hyde J . Exploring the folate pathway in Plasmodium falciparum. Acta Trop. 2005; 94(3):191-206. PMC: 2720607. DOI: 10.1016/j.actatropica.2005.04.002. View

20.

Xue J, Diao J, Cai G, Deng L, Zheng B, Yao Y . Antimalarial and Structural Studies of Pyridine-containing Inhibitors of 1-Deoxyxylulose-5-phosphate Reductoisomerase. ACS Med Chem Lett. 2013; 4(2):278-282. PMC: 3685428. DOI: 10.1021/ml300419r. View